✦ LIBER ✦

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

✍ Scribed by Mandelli, Franco; Avvisati, Giuseppe; Amadori, Sergio; Boccadoro, Mario; Gernone, Angela; Lauta, Vito M.; Marmont, Filippo; Petrucci, Maria T.; Tribalto, Maurizio; Vegna, Maria L.; Dammacco, Franco; Pileri, Alessandro

Book ID: 121871608
Publisher: Massachusetts Medical Society
Year: 1990
Tongue: English
Weight: 886 KB
Volume: 322
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJM199005173222005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interferon alfa-2b (INTRON A

Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol

✍ Mandelli, F.; Tribalto, M.; Avvisati, G.; Cantonetti, M.; Petrucci, M.T.; Boccad 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Interferon alfa-2b with VMCP compared to

Interferon alfa-2b with VMCP compared to VMCP alone for induction and interferon alfa-2b compared to controls for remission maintenance in multiple myeloma: Interim results

✍ Heinz Ludwig; Amos M. Cohen; Heinz Huber; David Nachbaur; Walter F. Jungi; Hansj 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 757 KB

The Interaction of Maintenance Interfero

The Interaction of Maintenance Interferon with Cytolytic Cells in Patients with Multiple Myeloma Who Responded to Cytotoxic Chemotherapy

✍ Philip D. Hall; Sally E. Self; Rayna Kneuper Hall 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Recombinant interferon-α2A as maintenanc

Recombinant interferon-α2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy

✍ Dr. Felicetto Ferrara; Vincenzo Rametta; Giuseppina Mele; Iolanda Antinolfi; Vin 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Continuous prednisolone versus conventio

Continuous prednisolone versus conventional prednisolone with VMCP–interferon-α2b as first-line chemotherapy in elderly patients with multiple myeloma

✍ Heinz Ludwig; Ivan Spicka; Pavel Klener; Richard Greil; Zdenek Adam; Heinz Gissl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Interferon alfa-2b/melphalan/prednisone

Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I–II trial

✍ M. Robert Cooper; Alexander Fefer; John Thompson; Delvyn C. Case; Raymond Kempf; 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 419 KB

Interferon alfa-2b (Intron A; Schering Plough) has been shown to be active in advanced previously treated multiple myeloma (MM). Recent in vitro evidence has suggested synergy between cytotoxic agents and interferon alfa-2b. This phase I-II protocol was initiated to study interferon alfa-2b in combi